Alutard Sq

Alutard Sq is a subcutaneous allergy treatment containing Dermatophagoides Pteronyssinus and Aluminium. It is designed to help manage allergic reactions by gradually desensitizing the immune system. This medication is manufactured by Alk-Abello A/S in the EU.

Alutard Sq is primarily used for the treatment of allergies caused by dust mites. It works by exposing the immune system to small amounts of the allergen, helping to reduce sensitivity over time. This process is known as allergen immunotherapy and is often recommended for individuals who experience persistent allergic symptoms.

Common effects of Alutard Sq may include localized reactions at the injection site, such as redness, swelling, or itching. Some individuals may also experience mild systemic reactions like sneezing or nasal congestion. These effects are generally temporary and should subside as the body adjusts to the treatment.

Alutard Sq should be administered under the supervision of a healthcare professional. It is important to inform your healthcare provider about any existing medical conditions or allergies before starting treatment. Always follow the prescribed dosage and administration schedule to minimize the risk of adverse reactions.

Alutard Sq may interact with certain medications, including beta-blockers and antihistamines. It is advisable to discuss all current medications with your healthcare provider to avoid potential interactions. Additionally, alcohol consumption should be moderated during treatment to prevent exacerbating any side effects.